Nantahala Capital Management - AMYLYX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,455,924
+110.1%
407,205
+147.5%
0.64%
+85.7%
Q2 2023$3,548,265164,5000.34%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Perceptive Advisors 5,472,033$154,038,0004.47%
Ghost Tree Capital, LLC 550,000$15,483,0004.35%
Ghost Tree Capital, LLC 500,000$14,075,0003.95%
Bain Capital Life Sciences Investors, LLC 1,023,214$28,803,0003.44%
Boxer Capital, LLC 2,084,000$58,665,0003.30%
Alpha Wave Global, LP 700,635$19,723,0002.33%
Soleus Capital Management, L.P. 429,336$12,086,0001.64%
Ikarian Capital, LLC 250,000$7,037,0001.40%
Cormorant Asset Management, LP 610,000$17,172,0001.20%
SECTORAL ASSET MANAGEMENT INC 205,400$5,782,0001.14%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders